Aesthetic Medicine Market Size, Share, and Trends 2024 to 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Route of Administration Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Aesthetic Medicine Market 

5.1. COVID-19 Landscape: Aesthetic Medicine Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Aesthetic Medicine Market, By Product Type

8.1. Aesthetic Medicine Market, by Product Type, 2024-2034

8.1.1. Energy-Based Devices

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Implants

8.1.2.1. Market Revenue and Forecast (2021-2034)

8.1.3. Anti-Wrinkle Products

8.1.3.1. Market Revenue and Forecast (2021-2034)

8.1.4. Dermal Fillers

8.1.4.1. Market Revenue and Forecast (2021-2034)

8.1.5. Botulinum Toxin

8.1.5.1. Market Revenue and Forecast (2021-2034)

8.1.6. Others

8.1.6.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Aesthetic Medicine Market, By Procedure Type

9.1. Aesthetic Medicine Market, by Procedure Type, 2024-2034

9.1.1. Non-Invasive Procedure

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Invasive Procedure

9.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Aesthetic Medicine Market, By Application Type 

10.1. Aesthetic Medicine Market, by Application Type, 2024-2034

10.1.1. Surgical

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Non-Surgical

10.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Aesthetic Medicine Market, By End-User Type

11.1. Aesthetic Medicine Market, by End-User Type, 2024-2034

11.1.1. Medical Spas and Beauty Centres

11.1.1.1. Market Revenue and Forecast (2021-2034)

11.1.2. Hospitals and Clinics

11.1.2.1. Market Revenue and Forecast (2021-2034)

11.1.3. Ambulatory Surgical Centers

11.1.3.1. Market Revenue and Forecast (2021-2034)

11.1.4. Others

11.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 12. Global Aesthetic Medicine Market, By Gender

12.1. Aesthetic Medicine Market, by Gender, 2024-2034

12.1.1. Males

12.1.1.1. Market Revenue and Forecast (2021-2034)

12.1.2. Females

12.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 13. Global Aesthetic Medicine Market, By Route of Administration

13.1. Aesthetic Medicine Market, by Procedure Type, 2024-2034

13.1.1. Oral

13.1.1.1. Market Revenue and Forecast (2021-2034)

13.1.2. Topical

13.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 14. Global Aesthetic Medicine Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Forecast, by Product (2021-2034)

14.1.2. Market Revenue and Forecast, by Procedure (2021-2034)

14.1.3. Market Revenue and Forecast, by Application (2021-2034)

14.1.4. Market Revenue and Forecast, by End-User (2021-2034)

14.1.5. Market Revenue and Forecast, by Gender (2021-2034)

14.1.6. Market Revenue and Forecast, by Route of Administration (2021-2034)

14.1.7. U.S.

14.1.7.1. Market Revenue and Forecast, by Product (2021-2034)

14.1.7.2. Market Revenue and Forecast, by Procedure (2021-2034)

14.1.7.3. Market Revenue and Forecast, by Application (2021-2034)

14.1.7.4. Market Revenue and Forecast, by End-User (2021-2034)

14.1.8. Market Revenue and Forecast, by Gender (2021-2034)

14.1.8.1. Market Revenue and Forecast, by Route of Administration (2021-2034) 

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Forecast, by Product (2021-2034)

14.1.9.2. Market Revenue and Forecast, by Procedure (2021-2034)

14.1.9.3. Market Revenue and Forecast, by Application (2021-2034)

14.1.9.4. Market Revenue and Forecast, by End-User (2021-2034)

14.1.10. Market Revenue and Forecast, by Gender (2021-2034)

14.1.11. Market Revenue and Forecast, by Route of Administration (2021-2034)

14.1.11.1.

14.2. Europe

14.2.1. Market Revenue and Forecast, by Product (2021-2034)

14.2.2. Market Revenue and Forecast, by Procedure (2021-2034)

14.2.3. Market Revenue and Forecast, by Application (2021-2034)

14.2.4. Market Revenue and Forecast, by End-User (2021-2034) 

14.2.5. Market Revenue and Forecast, by Gender (2021-2034)

14.2.6. Market Revenue and Forecast, by Route of Administration (2021-2034)

14.2.7.

14.2.8. UK

14.2.8.1. Market Revenue and Forecast, by Product (2021-2034)

14.2.8.2. Market Revenue and Forecast, by Procedure (2021-2034)

14.2.8.3. Market Revenue and Forecast, by Application (2021-2034)

14.2.9. Market Revenue and Forecast, by End-User (2021-2034) 

14.2.10. Market Revenue and Forecast, by Gender (2021-2034)

14.2.10.1. Market Revenue and Forecast, by Route of Administration (2021-2034) 

14.2.11. Germany

14.2.11.1. Market Revenue and Forecast, by Product (2021-2034)

14.2.11.2. Market Revenue and Forecast, by Procedure (2021-2034)

14.2.11.3. Market Revenue and Forecast, by Application (2021-2034)

14.2.12. Market Revenue and Forecast, by End-User (2021-2034)

14.2.13. Market Revenue and Forecast, by Gender (2021-2034)

14.2.14. Market Revenue and Forecast, by Route of Administration (2021-2034)

14.2.14.1.

14.2.15. France

14.2.15.1. Market Revenue and Forecast, by Product (2021-2034)

14.2.15.2. Market Revenue and Forecast, by Procedure (2021-2034)

14.2.15.3. Market Revenue and Forecast, by Application (2021-2034)

14.2.15.4. Market Revenue and Forecast, by End-User (2021-2034)

14.2.16. Market Revenue and Forecast, by Gender (2021-2034)

14.2.16.1. Market Revenue and Forecast, by Route of Administration (2021-2034)

14.2.17. Rest of Europe

14.2.17.1. Market Revenue and Forecast, by Product (2021-2034)

14.2.17.2. Market Revenue and Forecast, by Procedure (2021-2034)

14.2.17.3. Market Revenue and Forecast, by Application (2021-2034)

14.2.17.4. Market Revenue and Forecast, by End-User (2021-2034)

14.2.18. Market Revenue and Forecast, by Gender (2021-2034)

14.2.18.1. Market Revenue and Forecast, by Route of Administration (2021-2034)

14.3. APAC

14.3.1. Market Revenue and Forecast, by Product (2021-2034)

14.3.2. Market Revenue and Forecast, by Procedure (2021-2034)

14.3.3. Market Revenue and Forecast, by Application (2021-2034)

14.3.4. Market Revenue and Forecast, by End-User (2021-2034)

14.3.5. Market Revenue and Forecast, by Gender (2021-2034)

14.3.6. Market Revenue and Forecast, by Route of Administration (2021-2034)

14.3.7. India

14.3.7.1. Market Revenue and Forecast, by Product (2021-2034)

14.3.7.2. Market Revenue and Forecast, by Procedure (2021-2034)

14.3.7.3. Market Revenue and Forecast, by Application (2021-2034)

14.3.7.4. Market Revenue and Forecast, by End-User (2021-2034)

14.3.8. Market Revenue and Forecast, by Gender (2021-2034)

14.3.9. Market Revenue and Forecast, by Route of Administration (2021-2034)

14.3.10. China

14.3.10.1. Market Revenue and Forecast, by Product (2021-2034)

14.3.10.2. Market Revenue and Forecast, by Procedure (2021-2034)

14.3.10.3. Market Revenue and Forecast, by Application (2021-2034)

14.3.10.4. Market Revenue and Forecast, by End-User (2021-2034)

14.3.11. Market Revenue and Forecast, by Gender (2021-2034)

14.3.11.1. Market Revenue and Forecast, by Route of Administration (2021-2034)

14.3.12. Japan

14.3.12.1. Market Revenue and Forecast, by Product (2021-2034)

14.3.12.2. Market Revenue and Forecast, by Procedure (2021-2034)

14.3.12.3. Market Revenue and Forecast, by Application (2021-2034)

14.3.12.4. Market Revenue and Forecast, by End-User (2021-2034)

14.3.12.5. Market Revenue and Forecast, by Gender (2021-2034)

14.3.12.6. Market Revenue and Forecast, by Route of Administration (2021-2034)

14.3.13. Rest of APAC

14.3.13.1. Market Revenue and Forecast, by Product (2021-2034)

14.3.13.2. Market Revenue and Forecast, by Procedure (2021-2034)

14.3.13.3. Market Revenue and Forecast, by Application (2021-2034)

14.3.13.4. Market Revenue and Forecast, by End-User (2021-2034)

14.3.13.5. Market Revenue and Forecast, by Gender (2021-2034)

14.3.13.6. Market Revenue and Forecast, by Route of Administration (2021-2034)

14.4. MEA

14.4.1. Market Revenue and Forecast, by Product (2021-2034)

14.4.2. Market Revenue and Forecast, by Procedure (2021-2034)

14.4.3. Market Revenue and Forecast, by Application (2021-2034)

14.4.4. Market Revenue and Forecast, by End-User (2021-2034)

14.4.5. Market Revenue and Forecast, by Gender (2021-2034)

14.4.6. Market Revenue and Forecast, by Route of Administration (2021-2034)

14.4.7. GCC

14.4.7.1. Market Revenue and Forecast, by Product (2021-2034)

14.4.7.2. Market Revenue and Forecast, by Procedure (2021-2034)

14.4.7.3. Market Revenue and Forecast, by Application (2021-2034)

14.4.7.4. Market Revenue and Forecast, by End-User (2021-2034)

14.4.8. Market Revenue and Forecast, by Gender (2021-2034)

14.4.9. Market Revenue and Forecast, by Route of Administration (2021-2034)

14.4.10. North Africa

14.4.10.1. Market Revenue and Forecast, by Product (2021-2034)

14.4.10.2. Market Revenue and Forecast, by Procedure (2021-2034)

14.4.10.3. Market Revenue and Forecast, by Application (2021-2034)

14.4.10.4. Market Revenue and Forecast, by End-User (2021-2034)

14.4.11. Market Revenue and Forecast, by Gender (2021-2034)

14.4.12. Market Revenue and Forecast, by Route of Administration (2021-2034)

14.4.13. South Africa

14.4.13.1. Market Revenue and Forecast, by Product (2021-2034)

14.4.13.2. Market Revenue and Forecast, by Procedure (2021-2034)

14.4.13.3. Market Revenue and Forecast, by Application (2021-2034)

14.4.13.4. Market Revenue and Forecast, by End-User (2021-2034)

14.4.13.5. Market Revenue and Forecast, by Gender (2021-2034)

14.4.13.6. Market Revenue and Forecast, by Route of Administration (2021-2034)

14.4.14. Rest of MEA

14.4.14.1. Market Revenue and Forecast, by Product (2021-2034)

14.4.14.2. Market Revenue and Forecast, by Procedure (2021-2034)

14.4.14.3. Market Revenue and Forecast, by Application (2021-2034)

14.4.14.4. Market Revenue and Forecast, by End-User (2021-2034)

14.4.14.5. Market Revenue and Forecast, by Gender (2021-2034)

14.4.14.6. Market Revenue and Forecast, by Route of Administration (2021-2034)

14.5. Latin America

14.5.1. Market Revenue and Forecast, by Product (2021-2034)

14.5.2. Market Revenue and Forecast, by Procedure (2021-2034)

14.5.3. Market Revenue and Forecast, by Application (2021-2034)

14.5.4. Market Revenue and Forecast, by End-User (2021-2034)

14.5.5. Market Revenue and Forecast, by Gender (2021-2034)

14.5.6. Market Revenue and Forecast, by Route of Administration (2021-2034)

14.5.7. Brazil

14.5.7.1. Market Revenue and Forecast, by Product (2021-2034)

14.5.7.2. Market Revenue and Forecast, by Procedure (2021-2034)

14.5.7.3. Market Revenue and Forecast, by Application (2021-2034)

14.5.7.4. Market Revenue and Forecast, by End-User (2021-2034)

14.5.8. Market Revenue and Forecast, by Gender (2021-2034)

14.5.8.1. Market Revenue and Forecast, by Route of Administration (2021-2034)

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Forecast, by Product (2021-2034)

14.5.9.2. Market Revenue and Forecast, by Procedure (2021-2034)

14.5.9.3. Market Revenue and Forecast, by Application (2021-2034)

14.5.9.4. Market Revenue and Forecast, by End-User (2021-2034)

14.5.9.5. Market Revenue and Forecast, by Gender (2021-2034)

14.5.9.6. Market Revenue and Forecast, by Route of Administration (2021-2034)

Chapter 15. Company Profiles

15.1. AbbVie Inc.

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Galderma

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. Alma Lasers

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Cynosure

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. Johnson & Johnson Private Limited

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. Lumenis Be Ltd.

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. Solta Medical

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. Candela Medical

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. Hologic, Inc.

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. Dentsply Sirona

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms